Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

98 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders.
Balfour DJ, Fagerström KO. Balfour DJ, et al. Pharmacol Ther. 1996;72(1):51-81. doi: 10.1016/s0163-7258(96)00099-x. Pharmacol Ther. 1996. PMID: 8981571 Review.
Estimating the harms of nicotine-containing products using the MCDA approach.
Nutt DJ, Phillips LD, Balfour D, Curran HV, Dockrell M, Foulds J, Fagerstrom K, Letlape K, Milton A, Polosa R, Ramsey J, Sweanor D. Nutt DJ, et al. Among authors: balfour d. Eur Addict Res. 2014;20(5):218-25. doi: 10.1159/000360220. Epub 2014 Apr 3. Eur Addict Res. 2014. PMID: 24714502
A high-fat-diet-induced cognitive deficit in rats that is not prevented by improving insulin sensitivity with metformin.
McNeilly AD, Williamson R, Balfour DJ, Stewart CA, Sutherland C. McNeilly AD, et al. Among authors: balfour dj. Diabetologia. 2012 Nov;55(11):3061-70. doi: 10.1007/s00125-012-2686-y. Epub 2012 Aug 18. Diabetologia. 2012. PMID: 22898768
Atrial natriuretic factor attenuates prostaglandin E2-stimulated plasma renin activity in humans.
McMurray J, McFarlane L, Coutie W, Balfour D, Struthers A. McMurray J, et al. J Cardiovasc Pharmacol. 1989 Aug;14(2):326-30. doi: 10.1097/00005344-198908000-00021. J Cardiovasc Pharmacol. 1989. PMID: 2476609
Diagnosis and treatment of nicotine dependence with emphasis on nicotine replacement therapy. A status report.
Balfour D, Benowitz N, Fagerström K, Kunze M, Keil U. Balfour D, et al. Eur Heart J. 2000 Mar;21(6):438-45. doi: 10.1053/euhj.1999.1949. Eur Heart J. 2000. PMID: 10681484 Review.
Guidelines on nicotine dose selection for in vivo research.
Matta SG, Balfour DJ, Benowitz NL, Boyd RT, Buccafusco JJ, Caggiula AR, Craig CR, Collins AC, Damaj MI, Donny EC, Gardiner PS, Grady SR, Heberlein U, Leonard SS, Levin ED, Lukas RJ, Markou A, Marks MJ, McCallum SE, Parameswaran N, Perkins KA, Picciotto MR, Quik M, Rose JE, Rothenfluh A, Schafer WR, Stolerman IP, Tyndale RF, Wehner JM, Zirger JM. Matta SG, et al. Among authors: balfour dj. Psychopharmacology (Berl). 2007 Feb;190(3):269-319. doi: 10.1007/s00213-006-0441-0. Epub 2006 Aug 9. Psychopharmacology (Berl). 2007. PMID: 16896961 Review.
The role of mesoaccumbens dopamine in nicotine dependence.
Balfour DJ. Balfour DJ. Curr Top Behav Neurosci. 2015;24:55-98. doi: 10.1007/978-3-319-13482-6_3. Curr Top Behav Neurosci. 2015. PMID: 25638334 Review.
Nicotine: from molecular mechanisms to behaviour.
Wonnacott S, Sidhpura N, Balfour DJ. Wonnacott S, et al. Among authors: balfour dj. Curr Opin Pharmacol. 2005 Feb;5(1):53-9. doi: 10.1016/j.coph.2004.12.002. Curr Opin Pharmacol. 2005. PMID: 15661626 Review.
The neuronal pathways mediating the behavioral and addictive properties of nicotine.
Balfour DJ. Balfour DJ. Handb Exp Pharmacol. 2009;(192):209-33. doi: 10.1007/978-3-540-69248-5_8. Handb Exp Pharmacol. 2009. PMID: 19184651 Review.
Metabotropic glutamate receptor 5 as a potential target for smoking cessation.
Chiamulera C, Marzo CM, Balfour DJK. Chiamulera C, et al. Among authors: balfour djk. Psychopharmacology (Berl). 2017 May;234(9-10):1357-1370. doi: 10.1007/s00213-016-4487-3. Epub 2016 Nov 16. Psychopharmacology (Berl). 2017. PMID: 27847973 Review.
98 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback